MATWIN organises in Bordeaux on May 11th and 12th 2017 the 3rd edition of its Oncology Business Convention entirely dedicated to open innovation, collaborative research and technology transfer: MEET2WIN.
MATWIN is a national platform supporting innovation in oncology. The programme is based on a public/private partnership between pharma companies (Amgen, AstraZeneca, BMS, Celgene, GSK, Janssen, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi), UNICANCER and the Canceropôles. MATWIN objectives are :
- support projects to make them transferable
- bridge the gap between research innovations and industrial needs
- develop a better understanding of the market expectations
- improve and accelerate innovation transfer for the benefit of patients
The MEET2WIN convention is organised around one-to-one meetings and bringing together all the parties involved in oncology innovation, MEET2WIN offers the opportunity to meet representatives of big pharma & diag companies, biotechs, startups, researchers, clinicians, TTO’s, investors etc. to boost collaborations opportunities. MEET2WIN is supported by Enterprise Europe Network.
MEET2WIN is a one and a half day business convention combining conferences, elevator pitches, one-to-one prescheduled business meetings, networking time as well as an exhibition area.
MEET2WIN takes place place at the same time as the MATWIN International Board meeting. Participants will have the opportunity to exchange with the committee members: oncology academic key opinion leaders and industry international leaders.